TMDX · TransMedics Group, Inc. · Documents

Aug 1

Current report 8-K

Financial results

Jul 29

Current report 8-K

Entered into a material agreement, Ended a material agreement, New debt or off-balance-sheet obligation

Jun 2

Current report 8-K Events of Jun 1

Shareholder vote results

May 5

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $15.88M ▲ 125.2% Net loss $10.56M Diluted EPS -$0.38

May 3

Earnings call

Q1 2022 earnings call

May 3

Current report 8-K

Financial results

Apr 22

Proxy statement DEFA14A

Proxy statement

Apr 20

Proxy statement DEF 14A Meeting Jun 1, 2022

Proxy statement

Apr 20

Proxy statement DEFA14A

Proxy statement

Mar 1

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $30.26M ▲ 18.0% Net loss $44.22M Diluted EPS -$1.60

Feb 23

Earnings call

Q4 2021 earnings call

Feb 23

Current report 8-K

Financial results

Nov 9

Earnings call

Q3 2021 earnings call

Nov 9

Current report 8-K

Financial results

Nov 9

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $5.37M ▼ 24.3% Net loss $12.96M Diluted EPS -$0.47

Sep 29

Current report 8-K

Regulation FD disclosure

Sep 7

Current report 8-K

Regulation FD disclosure

Aug 9

Current report 8-K Events of Aug 4

Director or officer change, or executive pay

Aug 6

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $8.17M ▲ 141.0% Net loss $10.67M Diluted EPS -$0.39

Aug 5

Earnings call

Q2 2021 earnings call

Aug 5

Current report 8-K

Financial results

Jul 15

Current report 8-K Events of Jul 14

Regulation FD disclosure

May 28

Current report 8-K Events of May 27

Shareholder vote results

May 7

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $7.05M ▼ 6.3% Net loss $7.92M Diluted EPS -$0.29

May 4

Earnings call

Q1 2021 earnings call

May 4

Current report 8-K

Financial results

Apr 16

Proxy statement DEF 14A Meeting May 27, 2021

Proxy statement

Apr 16

Proxy statement DEFA14A

Proxy statement

Apr 7

Current report 8-K Events of Apr 6

Regulation FD disclosure

Mar 24

Current report 8-K Events of Mar 22

Director or officer change, or executive pay

Mar 11

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $25.64M ▲ 8.6% Net loss $28.75M

Mar 2

Earnings call

Q4 2020 earnings call

Mar 2

Current report 8-K

Financial results

Dec 23

Current report 8-K Events of Dec 17

Director or officer change, or executive pay

Nov 6

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $7.09M ▼ 1.6% Net loss $5.09M

Nov 4

Earnings call

Q3 2020 earnings call

Nov 4

Current report 8-K

Financial results

Aug 7

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $3.39M ▼ 40.2% Net loss $8.5M

Aug 5

Earnings call

Q2 2020 earnings call

Aug 5

Current report 8-K

Financial results

Jun 8

Current report 8-K Events of Jun 4

Shareholder vote results

Jun 5

Current report 8-K Events of Jun 2

Other events

Jun 2

Current report 8-K Events of Jun 1

Entered into a material agreement

May 28

Current report 8-K Events of May 26

Other events

May 26

Current report 8-K

Other events

May 6

Current report 8-K

Financial results

May 6

Quarterly report 10-Q FY2020 Q1, ended Mar 31

Quarterly report for FY2020 Q1

Revenue $7.53M ▲ 61.0% Net loss $8.85M

May 6

Registration statement S-3

Registration statement

Apr 28

Current report 8-K Events of Apr 27

Other events

Apr 24

Current report 8-K Events of Apr 20

Entered into a material agreement, New debt or off-balance-sheet obligation